Raff Christian, Dörr-Harim Colette, Otto Stephanie, Thiele Johanna, Mihaljevic Andre, Kramer Klaus
Department of General and Visceral Surgery, Working Group of Integrative Medicine, University Hospital Ulm, Ulm, Germany.
Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
JMIR Res Protoc. 2023 Oct 18;12:e46765. doi: 10.2196/46765.
Patients with cancer receiving neoadjuvant treatment prior to surgery are in a very stressful situation. Chemotherapy and radiation therapy put a strain on the quality of life and the pending surgery poses a relevant burden for many patients. Preparation of these patients for the intervention in terms of prehabilitation has great potential to reduce the burden of postoperative complications and may improve the clinical outcome. A prehabilitation approach also yields the possibility to address unmet patients' needs and to help them modify their lifestyle in a maintainable way. Therefore, a multimodal approach is mandatory during this critical period.
The aim of this study is to assess the feasibility of prehabilitation in an integrative medicine day clinic (PRIME-DC) prior to cancer surgery at a major university clinic. PRIME-DC is considered feasible if 80% of enrolled patients are willing and able to complete at least 6 out of the 8 weekly meetings, each lasting 6.5 hours, at such a clinic. Secondary end points aim to evaluate this multimodal program.
The PRIME-DC intervention combines mind-body medicine, exercise therapy, nutrition therapy, naturopathic counseling, and the application of a yarrow liver compress. Adult patients with cancer, with a primary tumor in the abdomen (including intraperitoneal cancer, stomach cancer, and extraperitoneal cancers such as pancreatic, bladder, rectal, esophageal, endometrial, ovarian, and cervical cancer) or the breast requiring a neoadjuvant oncological treatment setting are eligible to participate. The addressed cancer entities imply either an extensive surgical intervention with an expected need for prehabilitation (eg, abdominal surgery) or a neoadjuvant treatment of several months with a high burden of treatment-associated side effects (breast cancer). Adherence to the day clinic program is the primary end point being defined as presence during the day clinic session. Secondary end points are physical assessment and quality of life, together with a structured assessment of neoadjuvant treatment-associated side effects. Furthermore, to collect qualitative data voluntary participants of the day clinic will be interviewed in a semistructured way after completion of the day clinic program on each component of the study (mind-body intervention, exercise, nutrition, naturopathic counseling, and a yarrow liver compress).
The procedures used in this study adhere to the tenets of the Declaration of Helsinki. As of February 2023, we enrolled 23 patients; the dominant cancer entity is breast cancer (18 enrolled patients).
The presented protocol combines prehabilitation, lifestyle modification, naturopathic counseling, dietary assistance, and naturopathic treatment in an innovative and integrative way.
Deutsches Register Klinischer Studien German Clinical Trials Register DRKS00028126; https://drks.de/search/de/trial/DRKS00028126.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/46765.
接受术前新辅助治疗的癌症患者处于压力极大的状态。化疗和放疗给生活质量带来压力,而即将进行的手术给许多患者造成了相当大的负担。在术前康复方面让这些患者为干预做好准备,极有可能减轻术后并发症的负担,并可能改善临床结局。术前康复方法还提供了满足患者未被满足的需求并帮助他们以可持续方式改变生活方式的可能性。因此,在这个关键时期采用多模式方法是必不可少的。
本研究的目的是评估在一所大型大学诊所进行癌症手术前,综合医学日间诊所(PRIME-DC)开展术前康复的可行性。如果在这样的诊所中,80% 的入组患者愿意并能够完成每周8次会议中的至少6次,每次会议持续6.5小时,那么PRIME-DC被认为是可行的。次要终点旨在评估这个多模式项目。
PRIME-DC干预结合了身心医学、运动疗法、营养疗法、自然疗法咨询以及应用蓍草肝脏热敷。患有癌症的成年患者,其原发性肿瘤位于腹部(包括腹膜内癌症、胃癌以及腹膜外癌症,如胰腺癌、膀胱癌、直肠癌、食管癌、子宫内膜癌、卵巢癌和宫颈癌)或乳腺癌,且需要新辅助肿瘤治疗方案的,有资格参与。所涉及的癌症类型意味着要么需要进行广泛的手术干预且预计需要术前康复(例如腹部手术),要么需要进行数月的新辅助治疗且治疗相关副作用负担较重(乳腺癌)。对日间诊所项目的依从性是主要终点,定义为在日间诊所期间的出勤情况。次要终点包括身体评估和生活质量,以及对新辅助治疗相关副作用的结构化评估。此外,为了收集定性数据,日间诊所的自愿参与者将在日间诊所项目完成后,就研究的每个组成部分(身心干预、运动、营养、自然疗法咨询和蓍草肝脏热敷)接受半结构化访谈。
本研究中使用的程序符合《赫尔辛基宣言》的原则。截至2023年2月,我们招募了23名患者;主要癌症类型是乳腺癌(18名入组患者)。
所提出的方案以创新和综合的方式结合了术前康复、生活方式改变、自然疗法咨询、饮食辅助和自然疗法治疗。
德国临床试验注册中心German Clinical Trials Register DRKS00028126;https://drks.de/search/de/trial/DRKS00028126。
国际注册报告识别码(IRRID):DERR1-10.2196/46765。